Literature DB >> 16164440

Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance.

B Berghöfer1, T Frommer, I R König, A Ziegler, T Chakraborty, G Bein, H Hackstein.   

Abstract

BACKGROUND: Toll-like receptor 9 (TLR9) is a pattern-recognition receptor that detects unmethylated CpG motifs prevalent in bacterial and viral DNA. TLR9 stimulation is a key event after bacterial infection, triggering innate immunity and T-helper type 1 skewed adaptive immunity. Synthetic CpG-oligodeoxynucleotides (CpG-ODNs) represent a promising and novel class of immune adjuvants for allergy treatment, vaccination, and cancer therapy. However, common functional TLR9 gene variants could interfere with the clinical utilization of CpG-ODN in immunotherapy. Recently, a possible association of TLR9 polymorphism C-1237T with asthma has been reported.
OBJECTIVE: The aim of the present study was to investigate whether TLR9 polymorphisms or haplotypes have functional relevance and are associated with atopy.
METHODS: We genotyped five common TLR9 single-nucleotide polymorphisms (SNPs) in promoter, exon, and intron regions of the gene in 527 healthy blood donors, and estimated four common haplotypes. The total IgE and specific IgE levels against the most common aeroallergens were measured (n=303). IFN-alpha production by plasmacytoid dendritic cells (pDCs) was analysed after stimulation with TLR9 ligand CpG-ODN (n=220).
RESULTS: No significant influence of common TLR9 polymorphisms and haplotypes on the total and specific IgE levels was found. Functional analysis of CpG-ODN-induced IFN-alpha did not indicate a significant role for common TLR9 gene polymorphisms in TLR9 function.
CONCLUSION: We conclude that common genetic differences in the TLR9 gene exert no major influence on allergy susceptibility, and are unlikely to have on impact on clinical application of CpG-ODNs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164440     DOI: 10.1111/j.1365-2222.2005.02325.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  16 in total

1.  The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients.

Authors:  Ebru Onalan Etem; Halit Elyas; Salih Ozgocmen; Arefe Yıldırım; Ahmet Godekmerdan
Journal:  Rheumatol Int       Date:  2010-04-27       Impact factor: 2.631

2.  Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.

Authors:  Saumya Pandey; Balraj Mittal; Madhu Srivastava; Shalini Singh; Kirti Srivastava; Punita Lal; Rama Devi Mittal
Journal:  Mol Biol Rep       Date:  2010-12-05       Impact factor: 2.316

3.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

4.  A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

Authors:  Andriy V Kubarenko; Satish Ranjan; Anna Rautanen; Tara C Mills; Sunny Wong; Fredrik Vannberg; Michael Neumaier; Isabelle Bekeredjian-Ding; Adrian V S Hill; Parviz Ahmad-Nejad; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

5.  Toll-like receptor 9 affects severity of IgA nephropathy.

Authors:  Hitoshi Suzuki; Yusuke Suzuki; Ichiei Narita; Masashi Aizawa; Masao Kihara; Takahiro Yamanaka; Tatsuya Kanou; Hiroyasu Tsukaguchi; Jan Novak; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

Review 6.  Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.

Authors:  A Trejo-de la O; P Hernández-Sancén; C Maldonado-Bernal
Journal:  Genes Immun       Date:  2014-03-13       Impact factor: 2.676

7.  Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.

Authors:  Sabrina Zidi; Ikram Sghaier; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati
Journal:  Pathol Oncol Res       Date:  2015-11-09       Impact factor: 3.201

8.  Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease.

Authors:  Mike Tsz Hin Ng; Rob Van't Hof; Julie C Crockett; Mairi E Hope; Susan Berry; John Thomson; Mairi H McLean; Kenneth E L McColl; Emad M El-Omar; Georgina L Hold
Journal:  Infect Immun       Date:  2009-12-28       Impact factor: 3.441

9.  Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes.

Authors:  Nancy E Lange; Xiaobo Zhou; Jessica Lasky-Su; Blanca E Himes; Ross Lazarus; Manuel Soto-Quirós; Lydiana Avila; Juan C Celedón; Catherine M Hawrylowicz; Benjamin A Raby; Augusto A Litonjua
Journal:  BMC Med Genet       Date:  2011-02-15       Impact factor: 2.103

10.  Associations of allergic sensitization and clinical phenotypes with innate immune response genes polymorphisms are modified by house dust mite allergen exposure.

Authors:  Marcin Kurowski; Barbara Majkowska-Wojciechowska; Aleksandra Wardzyńska; Marek L Kowalski
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.